22P Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A real-world study from the ARON-2EV project
20260 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
22P Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A real-world study from the ARON-2EV project | Researchclopedia